Immunosuppression During Penetrating Keratoplasty, Using a Subconjunctival Implant Releasing Dexamethasone : Tolerance and Safety Pilot Study
PHASE2CompletedINTERVENTIONAL
Enrollment
14
Participants
Timeline
Start Date
January 10, 2017
Primary Completion Date
August 28, 2018
Study Completion Date
August 8, 2019
Conditions
KeratoconusFuchs' Endothelial DystrophyCongenital Hereditary Stromal Dystrophy of the Cornea
Interventions
DRUG
Dexamethasone implant OZURDEX
Trial Locations (1)
42055
CHU de Saint Etienne, Saint-Etienne
All Listed Sponsors
lead
Centre Hospitalier Universitaire de Saint Etienne
OTHER
NCT02834260 - Immunosuppression During Penetrating Keratoplasty, Using a Subconjunctival Implant Releasing Dexamethasone : Tolerance and Safety Pilot Study | Biotech Hunter | Biotech Hunter